PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
This study is registered with ClinicalTrials.gov identifier NCT02215265 .
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer | Synapse